Macrogenics MGNX
NASDAQ MGNX
$3.85 +0.08 (+2.12%)
As of: Sep 30, 2026 · 3:59 PM EDT

Macrogenics (MGNX) Capital Expenditures (2012 - 2026)

Updated

Macrogenics (MGNX) posted Capital Expenditures of $806,000 for Q2 2026, up 12.7% from $715,000 a year earlier and up 134.3% from the prior quarter.

Analysis

Macrogenics (MGNX) Capital Expenditures (2012 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Macrogenics was $1.82 million, down 25.9% year-over-year; for FY2025, it was $1.91 million, down 48.4% from FY2024.

  • Annual Capital Expenditures shows a five-year compound annual growth rate of -20.2% (FY2020 to FY2025).
  • In prior years, Macrogenics' Capital Expenditures was $3.71 million in FY2024 (+110.1%), $1.76 million in FY2023 (-51.3%), $3.62 million in FY2022 (-41.6%) and $6.2 million in FY2021 (+5.0%).
  • The Q2 2026 figure stands as the highest quarterly Capital Expenditures since Q2 2024.
  • On a year-over-year basis, Capital Expenditures increased in two of the last eight quarters, with an average decline of 23.4%.
  • The strongest year-over-year quarter for Capital Expenditures in the past five years was Q3 2021, with growth of 327.5%; the weakest was Q1 2023, with a decline of 74.6%.
  • According to Business Quant data, Capital Expenditures for the three prior quarters was $344,000 (Q1 2026), $244,000 (Q4 2025) and $426,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 1.32 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 322.00 Mn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -763.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 112.20 Mn
10 Macrogenics 239.94 Mn -77.83 Mn - 806,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 806,000.00
Mar 31, 2026 344,000.00
Dec 31, 2025 244,000.00
Sep 30, 2025 426,000.00
Jun 30, 2025 715,000.00
Mar 31, 2025 529,000.00
Dec 31, 2024 620,000.00
Sep 30, 2024 592,000.00
Jun 30, 2024 1.04 Mn
Mar 31, 2024 1.46 Mn
Dec 31, 2023 620,000.00
Sep 30, 2023 499,000.00
Jun 30, 2023 286,000.00
Mar 31, 2023 359,000.00
Dec 31, 2022 393,000.00
Sep 30, 2022 804,000.00
Jun 30, 2022 1.01 Mn
Mar 31, 2022 1.42 Mn
Dec 31, 2021 1.38 Mn
Sep 30, 2021 2.13 Mn
API Access

Macrogenics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=MGNX&period=max&api_key=YOUR_API_KEY